Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This synthetic peptide mimics the actions of naturally present GLP-1, a hormone https://socialmediatotal.com/story5870340/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes